|Bid||37.75 x 900|
|Ask||37.87 x 1000|
|Day's range||37.23 - 37.76|
|52-week range||30.95 - 52.46|
|Beta (5Y monthly)||0.48|
|PE ratio (TTM)||N/A|
|Earnings date||28 Jul 2020|
|Forward dividend & yield||3.36 (8.95%)|
|Ex-dividend date||12 Jun 2020|
|1y target est||47.86|
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better pick going forward?
With volatility through the roof over the last few months, finding a good dividend stock isn't as easy as it once was. With that in mind, let's take a look at three dividend stocks that are selling for cheap today. AT&T (NYSE: T) has lurched from one repositioning to the next over the last few years.
The U.S. International Trade Commission has announced a probe into Altria and Philip Morris for alleged patent violations over iQOS heat-not-burn technology.
Altria's (NYSE: MO) first-quarter earnings report saw sales surge 16% as shipment volumes jumped 6% from the year-ago period. It's also why Altria remains a top stock to buy even when the world isn't falling apart: Its products, like its Marlboro brand of cigarettes, are always in demand and it has been able to pay an ever-rising dividend for years. Shares of the domestic tobacco giant are down 26% this year due to troubles its investments in electronic cigarettes and marijuana have had, causing its payout to currently yield over 9% annually, but that makes its stock more attractive.
Altria Holds 2020 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.84 Per Common Share
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
Over the last 20 months, they have been impacted by valuation issues, a thriving black market, lower than expected demand, high inventory levels, mounting losses, health issues from the vaping scandals, and much more. The investor euphoria that surrounded cannabis stocks when Canada legalized marijuana for recreational use seems like a distant dream. The marijuana sector is still at a nascent stage and is expected to grow at a rapid pace in the upcoming decade.
With the prospects for global growth rapidly diminishing, electronic cigarette maker Juul Labs slashed its internal valuation by $7 billion, eliminating some 35% from the total and bringing it closer to the value assigned to it by its biggest investor, Altria (NYSE: MO). It's a major reversal for Juul Labs, and its tobacco giant partner too, as not too long ago the smoking-alternative leader saw significant expansion opportunities worldwide. Altria, after taking a $12.8 billion stake in Juul in 2018, has since written off three-quarters of the value of the investment.
Over the past 13 months, the marijuana industry has done a 180 -- and not the good kind. Following a first quarter in 2019 that saw more than a dozen pot stocks gain at least 70%, the past 13 months have featured across-the-board declines for North American cannabis stocks of 50% to 95%. Meanwhile, in the U.S., high tax rates on legal cannabis have made it virtually impossible for retailers to compete with the black market.
Staples stocks had a decent Q1 earnings season but will see negative currency translations in Q2. Plus, not all players in the sector are immune to coronavirus-led lockdowns.
Electronic cigarette leader Juul Labs is reportedly ready to withdraw from a handful of international markets because the regulatory environment has become overly hostile to the device. According to BuzzFeed News, Juul will soon remove its products from shelves in Austria, Belgium, Portugal, France, and Spain. The news outlet reports the European Union's strict requirement that e-cigs contain no more than 20 milligrams of nicotine makes it difficult for Juul and other manufacturers of tobacco alternatives to do business there.
Many investors prefer to invest in stocks they can hold on to forever. Another key offering that these companies bring to their shareholders is dividends. Altria has delivered impressive gains to its dividend investors over time.
Today's call is scheduled to last about one hour, including remarks by Altria's management and the question-and-answer session. This morning, Billy Gifford, Altria's CEO will discuss Altria's first quarter business results. Sal Mancuso, our CFO; and Murray Garnick, Executive Vice President and General Counsel, will join Billy in our Q&A session.
Tobacco, like alcohol, is considered a recession-resistant sector, and the first-quarter earnings report of Marlboro owner Altria (NYSE: MO) underscores why. While price increases helped boost revenue, Altria said "consumer pantry loading due to COVID-19" were a contributing factor to the gains. Net revenue rose to $5.6 billion, but consumers also traded down to cheaper brands, which resulted in its leading Marlboro brand losing 0.5 points of share across all cigarettes, which now stands at 42.8%, and maintaining its share of 56.9% in the premium cigarette category.
Altria's (MO) first-quarter 2020 results reflect growth in oral tobacco products and smokeable segments. Management withdraws 2020 earnings guidance due to coronavirus.
Altria (MO) delivered earnings and revenue surprises of 12.37% and 9.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Movement restrictions by governments have not hampered sales as most of the retail stores in which Altria sells its products were deemed to be essential businesses and remained open, the company said. Volume sales of smokeable tobacco rose 6.2%, while those of smokeless tobacco, such as snus and nicotine pouches, rose 2.8% in the three months ending March. In the months ahead, the company said it expects consumers to buy cheaper cigarettes as well as moist smokeless tobacco in the face of unemployment and weak consumer confidence due to the coronavirus pandemic.
Juul Labs is considering significant cuts to its workforce. The Wall Street Journal on Wednesday reported that the e-cigarette manufacturer, which is part-owned by tobacco giant Altria Group (NYSE: MO), is considering reducing staff by one-third, or about 900 workers. Juul is also facing more regulatory burdens, with the Federal Trade Commission recently seeking to end Altria's financial investment.